期刊文献+

TSG101基因在肉瘤中表达的初步研究 被引量:1

Preliminary Investigation of Expression of The Tumor Susceptibility Gene TSG101 in Sarcoma
下载PDF
导出
摘要 目的检测肿瘤易感基因TSG101在肉瘤的表达情况,探讨其表达在肉瘤发生中的可能作用。方法福尔马林固定、石蜡包埋40例肉瘤标本进行HE和TSG101免疫组织化学染色,观察TSG101的表达情况。结果肿瘤易感基因TSG101在肉瘤中的表达率较低,仅为17.5%。结论TSG101基因的缺陷可能是间叶组织来源恶性肿瘤的常发事件,其表达情况与恶性上皮组织肿瘤中的显著差异对两者的鉴别诊断可能有帮助。 Objective To detect the expression of the tumor susceptibility gene TSG101 in sarcoma to investigate the potential role of TSG101 in the pathogenesis of sarcoma. Methods 40 formalin fixed and paraffin embeded sarcoma tissues were stained by HE and immunohistochemistry to observe the expression of TSG101. Results The expression of TSG101 showed low level in sarcomas, with only 17. 5% positive rate. Conclusion The defect of tumor susceptibility gene TSG101 appeared to be a frequent event in cancers derived from mesenchymal tissues. The different expressing rate of TSGI01 in sarcomas and carcinomas implied a potential marker for differential diagnosis between them.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2005年第11期680-681,F0002,共3页 Cancer Research on Prevention and Treatment
基金 广东省自然科学基金资助项目(031881
关键词 肿瘤易感基因TSG101 肉瘤 免疫组织化学 Tumor susceptibility gene TSG101 Sarcoma Immunohistochemistry
  • 相关文献

参考文献10

二级参考文献45

  • 1[1]Bisson C, Blacher S, Polette M, et al. Restricted expression of menbrane type 1-matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells [J]. Int J Cancer, 2003,105(1): 7 - 13. 被引量:1
  • 2[2]Dalberg K, Eriksson E, Enberg U, et al. Gelatinase A,membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer [J]. World J Surg, 2000,24(3): 334 - 340. 被引量:1
  • 3[3]Ueno H, Nakamura H, Inoue M, et al. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas [J].Cancer Res, 1997, 57( 10): 2055 - 2056. 被引量:1
  • 4[4]Lhotak S, Elavathil LJ, Vukmirovic-Popovic S, et al.Immunolocalization of matrix metalloproteinases and their inhibitors in clinical specimens of bone metastasis from breast carcinoma [J]. Clin Exp Metastasis, 2000, 18(6): 463 -470. 被引量:1
  • 5[5]Jones JL, Glynn P, Walker RA. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas [J]. J Pathol, 1999, 189(2): 161 - 168. 被引量:1
  • 6[6]Heppner KJ, Matrisian LM, Jensen RA, et al. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response [J]. Am J Pathol,1996, 149 ( 1 ): 273 - 282. 被引量:1
  • 7[7]Polette M, Nawrocki B, Gilles C, et al. MT-MMP expression and localisation in human lung and breast cancers [J]. Virchows Arch, 1996,428(1):29-35. 被引量:1
  • 8[8]Okada A, Bellocq JP, Rouyer N, et al. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas [J].Proc Natl Acad Sci U S A, 1995, 92(7): 2730-2734. 被引量:1
  • 9[9]Ishigaki S, Toi M, Ueno T, et al. Significance of membrane type 1 matrix metalloproteinase expression in breast cancer [J]. Jpn J Cancer Res, 1999, 90(5): 516 - 522. 被引量:1
  • 10[10]Kim MH. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases [J]. J Cell Biochem, 2003, 89(3): 529 - 538. 被引量:1

共引文献14

同被引文献15

引证文献1

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部